Advocacy

The latest "Read on Washington" includes an update on the health care debate, additional details on fiscal year 2018 appropriations, events of interest, and more.

Appropriations negotiations for fiscal year 2018, the unveiling of the Senate Republicans' health care bill, and continued discussions on the future of federal support for health services research mean busy times for AcademyHealth.

This week's advocacy update includes links to summaries on the Senate's recently released health care bill, new articles on the proposal to move the Agency for Healthcare Research and Quality into the National Institutes of Health, and more.

​​​​​​​Beyond stories about the Senate’s health care bill, which run aplenty these days, we have seen more developments across our industry, including the president continuing to solidify members of his administration and the National Institutes of Health announcing a new initiative.

This blog is the second in a two-part series on the president’s fiscal year 2018 budget proposal.

The president's budget request is typically described by journalists and political pundits as "dead on arrival" regardless of who is in charge of what branch of government. Congress takes their constitutional "power of the purse" very seriously, and while lawmakers do take the president's request into consideration, they take pride in making their own funding decisions...

This advocacy update will center on federally funded research at the forces at play.

As can be expected, this week all eyes – ours included – have been on the president's proposed budget for fiscal year (FY) 2018, so today I'll provide a recap with all we know so far.

Today the president's budget was released, providing some much-needed detail to the "skinny budget" that was released in March. Today's release confirms the Administration's earlier proposal to move the Agency for Healthcare Research and Quality under the National Institutes of Health umbrella.

This week’s advocacy update will be shorter than last week’s, but there have been a few developments I wanted to be sure were on your radars.